Zandt F, Prior M, Kyrios M. Repetitive behaviour in children with high functioning autism and obsessive compulsive disorder. J Autism Dev Disord. 2006 Jul 25;37(2):251–9.
Geller D, Petty C, Vivas F, Johnson J, Pauls D, Biederman J. Examining the relationship between obsessive-compulsive disorder and attention-deficit/hyperactivity disorder in children and adolescents: a familial risk analysis. Biol Psychiatry. 2007;61(3):316–21.
Geller DA, Biederman J, Faraone SV, Cradock K, Hagermoser L, Zaman N, et al. Attention-deficit/hyperactivity disorder in children and adolescents with obsessive-compulsive disorder: fact or artifact? J Am Acad Child Adolesc Psychiatry. 2002;41(1):52–8.
Willcutt EG. The prevalence of DSM-IV attention-deficit/hyperactivity disorder: a meta-analytic review. Neurotherapeutics. 2012 Aug 15;9(3):490–9.
Reiff MI, Banez GA, Culbert TP. Children who have attentional disorders: diagnosis and evaluation. Pediatr Rev. 1993;14(12):455–65.
Biederman J, Faraone S, Milberger S, Curtis S, Chen L, Marrs A, et al. Predictors of persistence and remission of ADHD into adolescence: results from a four-year prospective follow-up study. J Am Acad Child Adolesc Psychiatry. 1996;35(3):343–51.
Biederman J, Faraone SV, Spencer T, Wilens T, Norman D, Lapey KA, et al. Patterns of psychiatric comorbidity, cognition, and psychosocial functioning in adults with attention deficit hyperactivity disorder. Am J Psychiatry. 1993;150(12):1792–8.
Faraone SV, Asherson P, Banaschewski T, Biederman J, Buitelaar JK, Ramos-Quiroga JA, et al. Attention-deficit/hyperactivity disorder. Nat Rev Dis PrimersNature Publishing Group. 2015;1(1):15020–3.
Association AP. Diagnostic and Statistical Manual of Mental Disorders (DSM-5®). American Psychiatric Pub; 2013. 1 p.
Delorme R, Golmard J-L, Chabane N, Millet B, Krebs M-O, Mouren-Simeoni MC, et al. Admixture analysis of age at onset in obsessive-compulsive disorder. Psychol Med. 2005;35(2):237–43.
Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen PsychiatryAmerican Medical Association. 2005;62(6):593–602.
Franke B, Faraone SV, Asherson P, Buitelaar J, Bau CHD, Ramos-Quiroga JA, et al. The genetics of attention deficit/hyperactivity disorder in adults, a review. Mol PsychiatryNature Publishing Group. 2012;17(10):960–87.
Faraone SV, Perlis RH, Doyle AE, Smoller JW, Goralnick JJ, Holmgren MA, et al. Molecular genetics of attention-deficit/hyperactivity disorder. Biol Psychiatry. 2005;57(11):1313–23.
van Grootheest DS, Cath DC, Beekman AT, Boomsma DI. Twin studies on obsessive-compulsive disorder: a review. Twin Res Hum Genet. 2005;8(5):450–8.
Taylor S. Etiology of obsessions and compulsions: a meta-analysis and narrative review of twin studies. Clin Psychol Rev Elsevier Ltd. 2011;31(8):1361–72.
Hudziak JJ, Van Beijsterveldt CEM, Althoff RR, Stanger C, Rettew DC, Nelson EC, et al. Genetic and environmental contributions to the child behavior checklist obsessive-compulsive scale: a cross-cultural twin study. Arch Gen Psychiatry. American Medical Association. 2004;61(6):608–16.
Maher B. Personal genomes: the case of the missing heritability. Nature. 2008;6:18–21.
Galéra C, Côté SM, Bouvard MP, Pingault J-B, Melchior M, Michel G, et al. Early risk factors for hyperactivity-impulsivity and inattention trajectories from age 17 months to 8 years. Arch Gen PsychiatryAmerican Medical Association. 2011;68(12):1267–75.
Demontis D, Walters RK, Martin J, Mattheisen M, Als TD, Agerbo E, et al. Discovery of the first genome-wide significant risk loci for attention deficit/hyperactivity disorder. Nat Genet. 2019;51(1):63–75.
Mattheisen M, Samuels JF, Wang Y, Greenberg BD, Fyer AJ, McCracken JT, et al. Genome-wide association study in obsessive-compulsive disorder: results from the OCGAS. Mol Psychiatry. 2014;20(3):337–44.
Stewart SE, Yu D, Scharf JM, Neale BM, Fagerness JA, Mathews CA, et al. Genome-wide association study of obsessive-compulsive disorder. Mol Psychiatry. 2013;18(7):788–98.
International Obsessive Compulsive Disorder Foundation Genetics Collaborative (IOCDF-GC) and OCD Collaborative Genetics Association Studies (OCGAS). Revealing the complex genetic architecture of obsessive-compulsive disorder using meta-analysis. Mol PsychiatryNature Publishing Group. 2018;23(5):1181–8.
Neale BM, Medland SE, Ripke S, Asherson P, Franke B, Lesch K-P, et al. Meta-analysis of genome-wide association studies of attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2010;49(9):884–97.
Pauls DL, Abramovitch A, Rauch SL, Geller DA. Obsessive–compulsive disorder: an integrative genetic and neurobiological perspective. Nat Rev Neurosci. 2014;15(6):410–24.
Faraone SV, Larsson H. Genetics of attention deficit hyperactivity disorder. Mol Psychiatry. 2019;12:1–14.
Middeldorp CM, Hammerschlag AR, Ouwens KG, Groen-Blokhuis MM, St Pourcain B, Greven CU, et al. A genome-wide association meta-analysis of attention-deficit/hyperactivity disorder symptoms in population-based pediatric cohorts. J Am Acad Child Adolesc PsychiatryElsevier. 2016;55(10):896.
Plomin R, Haworth CMA, Davis OSP. Common disorders are quantitative traits. Nat Rev GenetNature Publishing Group. 2009;10(12):872–8.
Bird A. Perceptions of epigenetics. Nature. 2007;447(7143):396–8.
Greally JM. A user’s guide to the ambiguous word “epigenetics.”. Nat Rev Mol Cell Biol. 2018;19.
Teh AL, Pan H, Chen L, Ong ML, Dogra S, Wong J, et al. The effect of genotype and in utero environment on interindividual variation in neonate DNA methylomes. Genome Res. 2014;24(7):1064–74.
Lappalainen T, Greally JM. Associating cellular epigenetic models with human phenotypes 2017;18(7):441–51. Available from: http://dx.doi.org/https://doi.org/10.1038/nrg.2017.32.
Bell JT, Tsai PC, Yang TP, Pidsley R, Nisbet J, Glass D. Epigenome-wide scans identify differentially methylated regions for age and age-related phenotypes in a healthy ageing population. PLoS Genet. 2012;8.
Grundberg E, Meduri E, Sandling JK, Hedman AK, Keildson S, Buil A. Global analysis of DNA methylation variation in adipose tissue from twins reveals links to disease-associated variants in distal regulatory elements. Am J Hum Genet. 2013;93.
Gertz J, Varley KE, Reddy TE, Bowling KM, Pauli F, Parker SL, et al. Analysis of DNA methylation in a three-generation family reveals widespread genetic influence on epigenetic regulation. Bickmore WA, editor. PLoS Genet. Public Library of Science; 2011 Aug 11;7(8):e1002228.
Chen L, Ge B, Casale FP, Vasquez L, Kwan T, Garrido-Martín D, et al. Genetic drivers of epigenetic and transcriptional variation in human immune cells. Cell. Elsevier; 2016 Nov 17;167(5):1398–1414.e24.
Banerjee TD, Middleton F, Faraone SV. Environmental risk factors for attention-deficit hyperactivity disorder. Acta Paediatr. 2007;96(9):1269–74.
Langley K, Holmans PA, van den Bree MB, Thapar A. Effects of low birth weight, maternal smoking in pregnancy and social class on the phenotypic manifestation of attention deficit hyperactivity disorder and associated antisocial behaviour: investigation in a clinical sample. BMC Psychiatry. 2007 Jun 20;7(1):30–8.
Froehlich TE, Anixt JS, Loe IM, Chirdkiatgumchai V, Kuan L, Gilman RC. Update on environmental risk factors for attention-deficit/hyperactivity disorder. Curr Psychiatry Rep Current Science Inc. 2011;13(5):333–44.
Brander G, Pérez-Vigil A, Larsson H, Mataix-Cols D. Systematic review of environmental risk factors for obsessive-compulsive disorder: a proposed roadmap from association to causation. Neurosci Biobehav RevElsevier Ltd. 2016;65:36–62.
Zilhão NR, Sugden K, Consortium B, Hoen PACT, van Meurs J, Isaacs A, et al. Epigenome-wide association study of attention-deficit/hyperactivity disorder symptoms in adults. BPSElsevier Inc. 2019;86(8):599–607.
Walton E, Pingault J-B, Cecil CAM, Gaunt TR, Relton CL, Mill J, et al. Epigenetic profiling of ADHD symptoms trajectories: a prospective, methylome-wide study. Mol Psychiatry. 2016;22(2):250–6.
Wilmot B, Fry R, Smeester L, Musser ED, Mill J, Nigg JT. Methylomic analysis of salivary DNA in childhood ADHD identifies altered DNA methylation in VIPR2. J Child Psychol Psychiatry. 2016;57(2):152–60.
Yue W, Cheng W, Liu Z, Tang Y, Lu T, Zhang D, et al. Genome-wide DNA methylation analysis in obsessive-compulsive disorder patients. Sci RepNature Publishing Group. 2016;2:1–7.
D'Addario C, Bellia F, Benatti B, Grancini B, Vismara M, Pucci M, et al. Exploring the role of BDNF DNA methylation and hydroxymethylation in patients with obsessive compulsive disorder. J Psychiatr ResElsevier. 2019;114:17–23.
Cappi C, Diniz JB, Requena GL, Lourenço T, Lisboa BCG, Batistuzzo MC, et al. Epigenetic evidence for involvement of the oxytocin receptor gene in obsessive– compulsive disorder. BMC NeurosciBioMed Central. 2016;30:1–8.
Jaffe AE, Gao Y, Deep-Soboslay A, Tao R, Hyde TM, Weinberger DR, et al. Mapping DNA methylation across development, genotype and schizophrenia in the human frontal cortex. Nat Neurosci. 2015;19(1):40–7.
Wockner LF, Noble EP, Lawford BR, Young RM, Morris CP, Whitehall VLJ, et al. Genome-wide DNA methylation analysis of human brain tissue from schizophrenia patients. Transl PsychiatryNature Publishing Group. 2019;24:1–8.
Hannon E, Dempster E, Viana J, Burrage J, Smith AR, Macdonald R, et al. An integrated genetic-epigenetic analysis of schizophrenia: evidence for co-localization of genetic associations and differential DNA methylation. Genome BiolGenome Biology. 2016;25:1–16.
Hannon E, Dempster E, Viana J, Burrage J, Smith AR, Macdonald R, et al. An integrated genetic-epigenetic analysis of schizophrenia: evidence for co-localization of genetic associations and differential DNA methylation. Genome Biol. 3rd ed. BioMed Central; 2016;17(1):176–116.
Crosbie J, Arnold P, Paterson A, Swanson J, Dupuis A, Li X, et al. Response inhibition and ADHD traits: correlates and heritability in a community sample. J Abnorm Child PsycholSpringer US. 2013;41(3):497–507.
Park LS, Burton CL, Dupuis A, Shan J, Storch EA, Crosbie J, et al. The Toronto obsessive-compulsive scale: psychometrics of a dimensional measure of obsessive-compulsive traits. J Am Acad Child Adolesc Psychiatry. 2016;55(4):310–4.
Fraser HB, Lam LL, Neumann SM, Kobor MS. Population-specificity of human DNA methylation. Genome Biol [Internet]. 2012;13(2):R8.
Bell JT, Pai AA, Pickrell JK, Gaffney DJ, Pique-Regi R, Degner JF, et al. DNA methylation patterns associate with genetic and gene expression variation in HapMap cell lines. Genome BiolBioMed Central Ltd. 2011;12(1):R10.
Scahill L, Riddle MA, McSwiggin-Hardin M, Ort SI, King RA, Goodman WK, et al. Children's Yale-Brown obsessive compulsive scale: reliability and validity. J Am Acad Child Adolesc Psychiatry. 1997;36(6):844–52.
Swanson JM, Schuck S, Porter MM, Carlson C, Hartman CA, Sergeant JA, et al. Categorical and dimensional definitions and evaluations of symptoms of ADHD: history of the SNAP and the SWAN rating scales. Int J Educ Psychol Assess. 3rd ed. 2012 Apr;10(1):51–70.
Burton CL, Wright L, Shan J, Xiao B, Dupuis A, Goodale T, et al. SWAN scale for ADHD trait-based genetic research: a validity and polygenic risk study. J Child Psychol Psychiatry. 2019;60(9):988–97.
Hanna GL, Piacentini J, Cantwell DP, Fischer DJ, Himle JA, Van Etten M. Obsessive-compulsive disorder with and without tics in a clinical sample of children and adolescents. Depress Anxiety. 2002;16(2):59–63.
Aryee MJ, Jaffe AE, Corrada-Bravo H, Ladd-Acosta C, Feinberg AP, Hansen KD, et al. Minfi: a flexible and comprehensive Bioconductor package for the analysis of Infinium DNA methylation microarrays. BioinformaticsOxford University Press. 2014;30(10):1363–9.
Houseman EA, Houseman E, Accomando WP, Koestler DC, Christensen BC, Marsit CJ, et al. DNA methylation arrays as surrogate measures of cell mixture distribution. BMC Bioinformatics [Internet]. 2012;13(1):–86.
Smith AK, Kilaru V, Klengel T, Mercer KB, Bradley B, Conneely KN, et al. DNA extracted from saliva for methylation studies of psychiatric traits: evidence tissue specificity and relatedness to brain. 2015;168B(1):36–44.
Lowe R, Gemma C, Beyan H, Hawa MI, Bazeos A, Leslie RD. Buccals are likely to be a more informative surrogate tissue than blood for epigenome-wide association studies. Epigenetics. 2014;8.
Reinius LE, Acevedo N, Joerink M, Pershagen GR, Pershagen G, Dahlen S-E, et al. Differential DNA methylation in purified human blood cells: implications for cell lineage and studies on disease susceptibility. Ting AH, editor. PLoS ONE [Internet]. 2012 Jul 25;7(7):e41361.
Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MAR, Bender D, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet. 2007;81(3):559–75.
Clayton D. snpStats: SnpMatrix and XSnpMatrix classes and methods. 2019.
Siu MT, Butcher DT, Turinsky AL, Cytrynbaum C, Stavropoulos DJ, Walker S, et al. Functional DNA methylation signatures for autism spectrum disorder genomic risk loci: 16p11.2 deletions and CHD8 variants. Clin Epigenetics. 2019;13:1–19.
Ameis SH, Lerch JP, Taylor MJ, Lee W, Viviano JD, Pipitone J, et al. A diffusion tensor imaging study in children with ADHD, autism spectrum disorder, OCD, and matched controls: distinct and non-distinct white matter disruption and dimensional brain-behavior relationships. Am J Psychiatry. 2016;173(12):1213–22.
Cross-Disorder Group of the Psychiatric Genomics Consortium. Electronic address: firstname.lastname@example.org, Cross-Disorder Group of the Psychiatric Genomics Consortium. Genomic relationships, novel loci, and pleiotropic mechanisms across eight psychiatric disorders. Cell. 2019 Dec 12;179(7):1469–1482.e11.
Bergen SE, O'Dushlaine CT, Ripke S, Lee PH, Ruderfer DM, Akterin S, et al. Genome-wide association study in a Swedish population yields support for greater CNV and MHC involvement in schizophrenia compared with bipolar disorder. Mol Psychiatry. 2012;17(9):880–6.
Levey DF, Gelernter J, Polimanti R, Zhou H, Cheng Z, Aslan M, et al. Reproducible genetic risk loci for anxiety: results from ∼200,000 participants in the million veteran program. Am J Psychiatry. 2020;177(3):223–32.
Trost S, Diekhof EK, Mohr H, Vieker H, Kramer B, Wolf C, et al. Investigating the impact of a genome-wide supported bipolar risk variant of MAD1L1 on the human reward systemNature Publishing Group. 2016;41(11):2679–87.
Ripke S, O'Dushlaine C, Chambert K, Moran JL, Kähler AK, Akterin S, et al. Genome-wide association analysis identifies 13 new risk loci for schizophrenia. Nat GenetNature Publishing Group. 2013;45(10):1150–9.
Pineda-Cirera L, Shivalikanjli A, Cabana-Domínguez J, Demontis D, Rajagopal VM, Børglum AD, et al. Exploring genetic variation that influences brain methylation in attention-deficit/hyperactivity disorder. Transl PsychiatrySpringer US. 2019;19:1–11.
Butcher DT, Cytrynbaum C, Turinsky AL, Siu MT, Inbar-Feigenberg M, Mendoza-Londono R, et al. CHARGE and kabuki syndromes: gene-specific DNA methylation signatures identify epigenetic mechanisms linking these clinically overlapping conditions. Am J Hum Genet. 2017;100(5):773–88.
Choufani S, Cytrynbaum C, Chung BHY, Turinsky AL, Grafodatskaya D, Chen YA, et al. NSD1 mutations generate a genome-wide DNA methylation signature. Nat Commun. 2015;6(1):109.